Bioanalytical Systems, Inc. To Host Third Quarter Conference Call on Tuesday, August 6.Business Editors, Health/Medical Writers BIOWIRE2K WEST LAFAYETTE West Lafayette, city (1990 pop. 25,907), Tippecanoe co., W Ind., a suburb of Lafayette, on the Wabash River; inc. 1924. A primarily residential city, it is the seat of Purdue Univ. , Ind.--(BW HealthWire)--July 30, 2002 Bioanalytical Systems (Nasdaq:BASI) announced today that the company will host a conference call at 9:00 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT on Tuesday, August 6, 2002 to discuss third quarter 2002 financial results for the period ended June 30, 2002. In addition, a press release announcing the results will be released prior to the market opening at 7:30 a.m. EDT on Tuesday, August 6, 2002. Peter Kissinger, President and Chief Executive Officer, Ronald Shoup, President and COO of Contract Research Operations, Doug Wieten, Chief Financial Officer, and Michael Silvon, Vice President -- Planning and Development, will host the call and will also discuss the Company's recently announced acquisitions, the real estate expansion program now under way and outlook for the coming quarters. Callers will have an opportunity to ask questions of the BAS BAS abbr. 1. Bachelor of Agricultural Science 2. Bachelor of Applied Science executives. To participate, please dial the following teleconferencing number five minutes prior to the scheduled conference time.
Date: Tuesday, August 6, 2002
Time: 9:00 a.m. Eastern Daylight Time
8:00 a.m. Central Daylight Time
7:00 a.m. Mountain Daylight Time
6:00 a.m. Pacific Daylight Time
Dial-In Number: 800-275-3939 (Domestic)
1-973-321-2000 (International)
Also, a live, listen-only Webcast of the conference call will be available at www.bioanalytical.com. For those unable to participate there will be a replay available from Tuesday, August 6 at 11:00 a.m. EDT through 11:59 p.m. EDT on Thursday, August 8, 2002. To listen to the replay, please dial:
Domestic: 877-519-4471
International: 1-973-341-3080
Replay Pin Code: 3409810
A replay of the Webcast will also be available at www.bioanalytical.com. In business for 28 years, BAS is a pharmaceutical development company whose research team has been recognized for its contributions to understanding disease and accelerating preclinical drug screening. BAS helps many of the top 25 pharmaceutical companies make people's lives better by bringing to market several billion dollars in new drugs for the treatment of central nervous system disorders Nervous system disorders A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency , diabetes, osteoporosis, HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. and other diseases. The company is an industry leader in systems used for new drug development, toxicology toxicology, study of poisons, or toxins, from the standpoint of detection, isolation, identification, and determination of their effects on the human body. Toxicology may be considered the branch of pharmacology devoted to the study of the poisonous effects of drugs. , and in cancer, addiction and behavioral research. Visit www.bioanalytical.com and www.culex Culex /Cu·lex/ (ku´leks) a genus of mosquitoes found throughout the world, many species of which are vectors of disease-producing organisms. Cu·lex n. .net for more about BAS. This release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the development of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks Operating risk The inherent or fundamental risk of a firm, without regard to financial risk. The risk that is created by operating leverage. Also called business risk. detailed in the company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion